Pfizer-biontech

The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.

US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.

Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday.

Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70 per cent protection against hospitalisation in South Africa in recent weeks, according to a major real-world study which suggests weaker efficacy against the new Omicron variant.

The Swiss medicines agency Swissmedic on Friday approved the vaccination of children aged between five and 11 with Pfizer-Biontech's Comirnaty vaccine.

The US Food and Drug Administration (FDA) on Thursday expanded authorization of the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds.

The UK government said late Wednesday it has ordered 114 million additional Covid-19 vaccine doses, from pharmaceutical giants Pfizer-BioNTech and Moderna, to bolster its jabs drive over the next two years.

Iraq said Saturday it has received 1.2 million doses of Pfizer-BioNTech's COVID-19 vaccine through the Covax sharing scheme, amid fears of a fourth wave in the country.

Canada on Friday became the latest country to authorize the Pfizer-BioNTech Covid-19 vaccine for children aged between five and 11-years-old, according to an official statement.

The United States can now start giving children aged 5-11 the Pfizer-BioNtech Covid vaccine, US health authorities said Tuesday as they gave final approval to this new phase of fighting the pandemic.

Pfizer-BioNTech submitted an authorization request to Health Canada on Monday for the use of its Covid-19 vaccine in children aged 5-11, the companies and the Canadian government said.

President Joe Biden will announce Wednesday the US plans to donate an additional 500 million Pfizer-BioNTech Covid vaccines to the rest of the world, bringing its total commitment to 1.1 billion, officials said.

New Zealand Prime Minister Jacinda Ardern on Monday extended a lockdown in Auckland by two weeks, while officials reported the country's first death linked to the Pfizer-BioNTech COVID-19 vaccine.

A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate.

The effectiveness of the Pfizer-BioNTech vaccine against Covid-19 declines faster than that of the AstraZeneca jab, according to a new study published on Thursday.

The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.

US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.

Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday.

Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70 per cent protection against hospitalisation in South Africa in recent weeks, according to a major real-world study which suggests weaker efficacy against the new Omicron variant.

The Swiss medicines agency Swissmedic on Friday approved the vaccination of children aged between five and 11 with Pfizer-Biontech's Comirnaty vaccine.

The US Food and Drug Administration (FDA) on Thursday expanded authorization of the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds.

The UK government said late Wednesday it has ordered 114 million additional Covid-19 vaccine doses, from pharmaceutical giants Pfizer-BioNTech and Moderna, to bolster its jabs drive over the next two years.

Iraq said Saturday it has received 1.2 million doses of Pfizer-BioNTech's COVID-19 vaccine through the Covax sharing scheme, amid fears of a fourth wave in the country.

Canada on Friday became the latest country to authorize the Pfizer-BioNTech Covid-19 vaccine for children aged between five and 11-years-old, according to an official statement.

The United States can now start giving children aged 5-11 the Pfizer-BioNtech Covid vaccine, US health authorities said Tuesday as they gave final approval to this new phase of fighting the pandemic.

Pfizer-BioNTech submitted an authorization request to Health Canada on Monday for the use of its Covid-19 vaccine in children aged 5-11, the companies and the Canadian government said.

President Joe Biden will announce Wednesday the US plans to donate an additional 500 million Pfizer-BioNTech Covid vaccines to the rest of the world, bringing its total commitment to 1.1 billion, officials said.

New Zealand Prime Minister Jacinda Ardern on Monday extended a lockdown in Auckland by two weeks, while officials reported the country's first death linked to the Pfizer-BioNTech COVID-19 vaccine.

A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate.

The effectiveness of the Pfizer-BioNTech vaccine against Covid-19 declines faster than that of the AstraZeneca jab, according to a new study published on Thursday.